ClinicalTrials.Veeva

Menu

Explainable Machine Learning for Predicting Early Gastric Cancer

W

Wenzhou Central Hospital

Status

Invitation-only

Conditions

Early Gastric Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT07047937
202506031607000064611

Details and patient eligibility

About

Abstract Background: Early detection of gastric cancer is crucial for improving patient survival rates. Currently, the primary method for diagnosing early-stage gastric cancer is endoscopy, which has various limitations. Additionally, single laboratory tests continue to fall short of the requirements for early screening. This study aims to develop a machine learning (ML) model using clinical data to predict early-stage gastric cancer and apply SHapley Additive exPlanation (SHAP) values to explain the ML model.

Methods: This study involved patients who provided gastric tissue samples at Wenzhou Central Hospital from 2019 to 2023. The investigators gathered various laboratory test results from these patients. The investigators constructed and evaluated nine ML models to predict early-stage gastric cancer, using the area under the curve (AUC), accuracy, and sensitivity to assess their performance. For the most effective prediction model, The investigators utilized the SHAP method to determine the features' importance and explain the ML model.

Enrollment

10 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all patients with a gastric tissue pathology result are included

Exclusion criteria

  • unclear or incomplete pathology results
  • significant missing laboratory data
  • progressive and advanced gastric cancer

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems